This article is more than 5 years old. Information may no longer be current.

Inspire to sell 2.2 million shares

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DURHAM, N.C. — Inspire Pharmaceuticals has agreed to sell 2.2 million shares of common stock to Deutsche Bank Securities and has granted the bank an option to purchase up to an additional 330,000 shares. Closing on the deal is expected on Monday, the company announced in a press release.

Inspire currently markets Elestat and Restasis with marketing partner Allergan.